about
Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressi...
Read More199.7K XNAS Volume
XNAS 06 May, 2025 5:30 PM (EDT)
Board Meeting
The next board meeting for Adicet Bio Inc is on 14 May 2025 for the purpose of Adicet Bio Inc First Quarter Earnings Results for 2025
See details
Not Eligible
Expensive Valuation
Technically Bearish
Adicet Bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..